Full Text View
Tabular View
No Study Results Posted
Related Studies
High Intensity Light Therapy in Alzheimer's Disease
This study has been completed.
Study NCT00065689   Information provided by National Center for Complementary and Alternative Medicine (NCCAM)
First Received: July 31, 2003   Last Updated: July 24, 2006   History of Changes

July 31, 2003
July 24, 2006
March 2003
 
 
 
Complete list of historical versions of study NCT00065689 on ClinicalTrials.gov Archive Site
 
 
 
High Intensity Light Therapy in Alzheimer's Disease
High Intensity Light Therapy in Alzheimer's Disease

The purpose of this study is to determine whether bright light improves the sleep, mood, and behavior of persons with Alzheimer's disease and related dementias (AD) who live in long-term care settings and, if so, to determine the best timing for the light therapy. The light levels being used in the study have been shown to improve depression in persons with seasonal affective disorder (SAD) and to relieve sleep problems in persons with jet lag and other body rhythm disturbances. Because persons with AD often will not remain still in front of a fluorescent panel, this project has involved renovations in the study units that provide for even, regulated, high-intensity light in all public areas of the study settings.

See Brief Summary

Phase III
Interventional
Treatment, Randomized, Single Blind, Dose Comparison, Crossover Assignment, Efficacy Study
  • Alzheimer's Disease
  • Dementia
Device: high-intensity light therapy
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
107
September 2005
 

Inclusion criteria:

  • Diagnosis of dementia
  • Residence on study units

Exclusion criteria:

  • Bipolar disorder
  • Severe retinal (eye) disease
Both
55 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00065689
 
R01 AT000212-01A1, SloaneP
National Center for Complementary and Alternative Medicine (NCCAM)
 
Principal Investigator: Philip D. Sloane, MD, MPH
National Center for Complementary and Alternative Medicine (NCCAM)
July 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP